Clinical Pharmacogenomics: Premarketing Evaluation in Early Phase Clinical Studies
Links shared publicly online about this topic.
- 480total visits
Clinical Pharmacogenomics: Premarketing Evaluation in Early Phase Clinical Studies
fda.gov —
Clinical Pharmacogenomics: Premarketing Evaluation in Early Phase Clinical Studies
View full resource at fda.gov
Most Recently Shared on February 25, 2011 at 8:57 pm By:
FDA releases guidance on Clinical Pharmacogenomics to provide recommendations on using genomic info to guide drug devp. http://bit.ly/eGczbL
Microsoft Word - 20043332-1159125-pi.doc
ofr.gov — “Microsoft Word - 20043332-1159125-pi.doc” View full resource at ofr.gov
Most Recently Shared on February 17, 2011 at 2:34 pm By:
eyeonfda Pharma and Health Lawyer
FDA Draft Guidance for Industry on Clinical Pharmacogenomics: Premarketing Evaluation in Early Phase Clinical Studies http://ow.ly/3YfcP
Advertisement
